Interference between mutational load, immune signatures and outcome in patients with head and neck cancer treated with definitive chemoradiation: A multicenter study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

Inge Tinhofer,Theresa Eder,Anne-Katrin Hess,Vanessa Fleischer,Panagiotis Balermpas,Claus Rödel,A. Linge,Mechthild Krause,M. Baumann,M. Stuschke,D. Zips,Henning Sebastian Schafer,Anca Grosu,Amir Abdollahi,Juergen Debus,Claus Belka,S. Pigorsch,Gabriele Multhoff,Stephanie E. Combs,Volker Budach,Dktk-Rog

Interference between mutational load, immune signatures and outcome in patients with head and neck cancer treated with definitive chemoradiation: A multicenter study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

2018

6047Background: Mutational load and immune expression signatures have previously been established as efficacy biomarkers in immune checkpoint inhibitor (ICI) trials. It is important to know the val...

Keywords:

Cancer
Radiation
Immune system
Head and neck cancer
Pathology
Medicine
German
Oncology
in patient
Internal medicine
immune checkpoint inhibitors
radiation oncology
multicenter study
Biomarker (medicine)

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations